The Drug Enforcement Administration issued a final rule regarding the rescheduling of hydrocodone combination products from schedule III to schedule II of the Controlled Substances Act.
Health information network Surescripts has brought on Tom Skelton as its new CEO, the company announced Thursday.
Restricting access to samples of generic biological drugs would lead to nearly $140 million in lost savings for every $1 billion in biologics sales, Matrix Global Advisors said.
The generic drug industry — and by extension, patients across the United States — is being adversely impacted by what some are calling branded drug makers’ abuse of risk evaluation and mitigation strategies, or REMS.
Brandperx in November will be launching its Patientperx platform, a diseases-state specific health resource that's being published in partnership with Reader's Digest.
As health care in the United States continues to move toward a patient-centric system, new opportunities are opening up for technology providers.
Despite creating a detailed plan to speed up the rate at which generic drug applications are reviewed, experts say a backlog has developed at the Food and Drug Administration’s Office of Generic Drugs.
“It’s not enough to pull drowning victims out of the river. You have to walk upstream to find out who’s throwing them in.” Physician and educator David Kilgore invoked that piece of wisdom from Episcopal bishop V. Gene Robinson to describe the current state of medicine in the United States — and the steps needed to drag the nation’s outmoded, costly and inefficient healthcare system into the 21st century.
Pharmacists aren’t the only professionals grappling with the uncertainties of health reform, shifting patient-care delivery models and changing reimbursement standards.
Despite a rocky start, the full rollout of health reform under the Affordable Care Act has already brought major benefits to the nation’s troubled health system and affordable coverage to millions of formerly uninsured or underinsured Americans, one of the Obama administration’s top health officials asserted recently.